Tag Archives: Lumena Pharmaceuticals

April, 2015

  • 9 April

    Shire’s Rare Liver Disease Drug Fails its Mid-Stage Study

    Shire’s investigational treatment for a rare and life-threatening genetic disorder failed to meet goals in a mid-stage study. Shire said that its Phase II IMAGO trial of its investigational compound SHP625 (LUM001) did not meet the primary or secondary endpoints in the study of 20 pediatric patients with Alagille syndrome …